The Effect of Isatin β Thiosemicarbazone (IBT)-related Compounds on IBT-resistant and on IBT-dependent Mutants of Vaccinia Virus

References

1. Appleyard G., Hume V. B. M., Westwood J. C. N. 1965; The effect of thiosemicarbazones on the growth of rabbitpox virus in tissue culture. Annals of the New York Academy of Sciences 130:92–104
   [Google Scholar]
2. Bauer D. J. 1963; The chemotherapy of ectromelia infection with isatin β-dialkylthiosemicarbazones. The British Journal of Experimental Pathology 44:233–242
   [Google Scholar]
3. Brockman R. W., Sidwell R. W., Arnett G., Shaddix S. 1970; Heterocyclic thiosemicarbazones: correlation between structure, inhibition of ribonucleotide reductase and inhibition of DNA viruses. Proceedings of the Society for Experimental Biology and Medicine 133:609–614
   [Google Scholar]
4. Deconti R. C., Toftness B. R., Agrawal K. C., Tomchick R., Mead J. A. R., Bertino J. R., Sartorelli A. C., Creasey W. A. 1972; Clinical and pharmacological studies with 5-hydroxy-2-formyIpyridine thiosemicarbazone. Cancer Research 32:1455–1462
   [Google Scholar]
5. Easterbrook K. B. 1961; Interference with the maturation of vaccinia virus by isatin β-thiosemicarbazone. Virology 17:245–251
   [Google Scholar]
6. Joklik W. K., Becker Y. 1964; The replication and coating of vaccinia DNA. Journal of Molecular Biology 10:452–474
   [Google Scholar]
7. Katz E., Margalith E., Winer B. 1973; An isatin β -thiosemicarbazonc (IBT)-dependent mutant of vaccinia virus: the nature of the IBT-dependent step. Journal of General Virology 21:477–484
   [Google Scholar]
8. Katz E., Margalith E., Winer B., Goldblum N. 1973a; Synthesis of vaccinia virus polypeptides in the presence of isatin-β -thiosemicarbazone. Antimicrobial Agents and Chemotherapy 4:44–48
   [Google Scholar]
9. Katz E., Margalith E., Winer B., Lazar A. 1973a; Characterization and mixed infections of three strains of vaccinia virus: wild type, IBT-resistant and IBT-dependent mutants. Journal of General Virology 21:469–475
   [Google Scholar]
10. Katz E., Winer B., Margalith E., Goldblum N. 1973c; Isolation and characterization of an IBT-dependent mutant of vaccinia virus. Journal of General Virology 19:161–164
    [Google Scholar]
11. Rolly H., Winkelman E. 1971; A new thiosemicarbazone active in vivo against vaccinia virus. In Advances in Antimicrobial and Antineoplastic Chemotherapy305–307 Edited by Hejzlar M. Semonsky M., Masak S. Munchen and Berlin: Urban & Schwarzenberg;
    [Google Scholar]
12. Salzman N. P. 1960; The rate of formation of vaccinia deoxyribonucleic acid and vaccinia virus. Virology 10:150–152
    [Google Scholar]
13. Sheffield R. W., Bauer D. J., Stephenson S. 1960; The protection of tissue cultures by isatin β thiosemicarbazone from the cytopathic effects of certain pox viruses. The British Journal of Experimental Pathology 41:638–647
    [Google Scholar]
14. Tsunoda A., Miyazaki K., Aota T., Matsumoto S., Kumagai K., Ishada N. 1971; Antivaccinia activity of y thiochromanone-1-thiosemicarbazone in vitro and in vivo. Japanese Journal of Microbiology 16:61–66
    [Google Scholar]
15. Woodson B., Joklik W. K. 1965; The inhibition of vaccinia virus multiplication by isatin ft thiosemicarbazone. Proceedings of the National Academy of Sciences of the United States of America 54:946–953
    [Google Scholar]
16. Zylber E. A., Penman S. 1970; The effect of high ionic strength on monomers, polyribosomes, and puromycin-treated polyribosomes. Biochimica et Biophysica Acta 204221–229
    [Google Scholar]